genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
19 January 2018
Hardman Report: Hepatitis C point-of-care diagnostic launched
View all reports >
Monday March 27, 2017
Genedrive shifts into higher gear as hepatitis C test enters new markets
Thursday January 18, 2018
Genedrive's Hepatitis C test is quick, effective and simple to use, say analysts
Wednesday January 17, 2018
Genedrive making “good progress” as it hurtles towards commercialisation of its hep C test
View all news >
© 2017-18 genedrive plc
Don't show this again